United States Biotechnology & Medical Research

Theseus Pharmaceuticals Inc (THRX)

Track

Ticker: THRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Theseus Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
ORBIMED ADVISORS LLC
2 purchases — total 1,463,793 USD
Buy 17 Jul 2023
Value US$1,285,105.79 | Price 84.98 | Shares 46,288
Buy 17 Jul 2023
Value US$291,622.86 | Price 67.62 | Shares 61,800
Buy 17 Jul 2023
Value US$684,382.82 | Price 243.40 | Shares 17,039
Buy 17 Jul 2023
Value US$3,423,579.05 | Price 330.53 | Shares 71,615
Buy 17 Jul 2023
Value US$524,353.50 | Price 2.97 | Shares 176,550
Buy 17 Jul 2023
Value US$1,554,646.50 | Price 2.97 | Shares 523,450
Buy 30 Dec 2022
Value US$49,489.11 | Price 5.00 | Shares 9,900
Buy 29 Dec 2022
Value US$500.00 | Price 5.00 | Shares 100
Buy 29 Dec 2022
Value US$1,250,000.00 | Price 5.00 | Shares 250,000
Buy 29 Dec 2022
Value US$1,250,000.00 | Price 5.00 | Shares 250,000
Planned buy 30 Nov 2022
Value US$10,000.07 | Price 6.66 | Shares 1,502
Buy 11 Nov 2022
Value US$16,995.00 | Price 6.80 | Shares 2,500
Buy 7 Nov 2022
Value US$1,000,320.00 | Price 5.21 | Shares 192,000
Buy 7 Nov 2022
Value US$1,000,320.00 | Price 5.21 | Shares 192,000
Buy 21 Jan 2022
Value US$1,115,603.12 | Price 9.97 | Shares 111,896
Buy 21 Jan 2022
Value US$1,115,603.12 | Price 9.97 | Shares 111,896
Buy 20 Jan 2022
Value US$348,250.00 | Price 9.95 | Shares 35,000
Buy 20 Jan 2022
Value US$348,250.00 | Price 9.95 | Shares 35,000
Buy 19 Jan 2022
Value US$114,864.37 | Price 9.97 | Shares 11,521
Buy 19 Jan 2022
Value US$114,864.37 | Price 9.97 | Shares 11,521
Buy 13 Jan 2022
Value US$163,327.60 | Price 9.43 | Shares 17,320
Buy 13 Jan 2022
Value US$163,327.60 | Price 9.43 | Shares 17,320
Buy 12 Jan 2022
Value US$190,103.82 | Price 10.06 | Shares 18,897
Buy 12 Jan 2022
Value US$190,103.82 | Price 10.06 | Shares 18,897
Buy 11 Jan 2022
Value US$73,623.00 | Price 10.67 | Shares 6,900
Buy 11 Jan 2022
Value US$15,696.00 | Price 9.81 | Shares 1,600
Buy 11 Jan 2022
Value US$73,623.00 | Price 10.67 | Shares 6,900
Buy 11 Jan 2022
Value US$15,696.00 | Price 9.81 | Shares 1,600
Buy 21 Dec 2021
Value US$25,381.46 | Price 9.76 | Shares 2,600
Buy 21 Dec 2021
Value US$20,000.00 | Price 10.15 | Shares 1,970
Buy 12 Oct 2021
Value US$4,000,000.00 | Price 16.00 | Shares 250,000
Buy 12 Oct 2021
Value US$1,000,000.00 | Price 16.00 | Shares 62,500
Buy 12 Oct 2021
Value US$9,000,000.00 | Price 16.00 | Shares 562,500
Buy 12 Oct 2021
Value US$10,000.00 | Price 16.00 | Shares 625
Buy 12 Oct 2021
Value US$1,000,000.00 | Price 16.00 | Shares 62,500
Buy 12 Oct 2021
Value US$9,000,000.00 | Price 16.00 | Shares 562,500
Buy 12 Oct 2021
Value US$3,000,000.00 | Price 16.00 | Shares 187,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-19 2023-07-17 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
46,288 -13.1%
84.98
US$1,285,106 		46,288 -13.1% 84.98 US$1,285,106
2023-07-19 2023-07-17 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
61,800 -37.1%
67.62
US$291,623 		61,800 -37.1% 67.62 US$291,623
2023-07-19 2023-07-17 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
17,039 -27.6%
243.40
US$684,383 		17,039 -27.6% 243.40 US$684,383
2023-07-19 2023-07-17 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
328,482 +2.0%
3.05
US$1,001,870 		328,482 +2.0% 3.05 US$1,001,870
2023-07-19 2023-07-17 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
176,550 +14.6%
2.97
US$524,354 		176,550 +14.6% 2.97 US$524,354
2023-07-19 2023-07-17 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
523,450 +14.6%
2.97
US$1,554,646 		523,450 +14.6% 2.97 US$1,554,646
2023-01-03 2022-12-30 B Purchase
3.7
HAYDEN DONALD J JR
Non-Executive Director
9,900 +9900.0%
5.00
US$49,489 		9,900 +9900.0% 5.00 US$49,489
2023-01-03 2022-12-29 B Purchase
3.7
HAYDEN DONALD J JR
Non-Executive Director
100 +inf%
5.00
US$500 		100 +inf% 5.00 US$500
2023-01-03 2022-12-29 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
250,000 +26.1%
5.00
US$1,250,000 		250,000 +26.1% 5.00 US$1,250,000
2023-01-03 2022-12-29 B Purchase
3.4
Foresite Capital Management V, LLC
Large shareholder
250,000 +7.5%
5.00
US$1,250,000 		250,000 +7.5% 5.00 US$1,250,000
2022-12-01 2022-11-30 PP Planned purchase
2.4
Dahms Bradford D.

Chief Financial Officer

Officer
1,502 +32.4%
6.66
US$10,000 		1,502 +32.4% 6.66 US$10,000
2022-11-14 2022-11-11 B Purchase
3.1
CLACKSON TIMOTHY P

President and CEO

Executive Director
2,500 +0.7%
6.80
US$16,995 		2,500 +0.7% 6.80 US$16,995
2022-11-09 2022-11-07 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
192,000 +1.2%
5.21
US$1,000,320 		192,000 +1.2% 5.21 US$1,000,320
2022-11-09 2022-11-07 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
192,000 +1.2%
5.21
US$1,000,320 		192,000 +1.2% 5.21 US$1,000,320
2022-01-21 2022-01-21 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
111,896 +0.7%
9.97
US$1,115,603 		111,896 +0.7% 9.97 US$1,115,603
2022-01-21 2022-01-21 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
111,896 +0.7%
9.97
US$1,115,603 		111,896 +0.7% 9.97 US$1,115,603
2022-01-21 2022-01-20 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
35,000 +0.2%
9.95
US$348,250 		35,000 +0.2% 9.95 US$348,250
2022-01-21 2022-01-20 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
35,000 +0.2%
9.95
US$348,250 		35,000 +0.2% 9.95 US$348,250
2022-01-21 2022-01-19 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
11,521 +0.1%
9.97
US$114,864 		11,521 +0.1% 9.97 US$114,864
2022-01-21 2022-01-19 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
11,521 +0.1%
9.97
US$114,864 		11,521 +0.1% 9.97 US$114,864
2022-01-13 2022-01-13 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
17,320 +0.1%
9.43
US$163,328 		17,320 +0.1% 9.43 US$163,328
2022-01-13 2022-01-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
17,320 +0.1%
9.43
US$163,328 		17,320 +0.1% 9.43 US$163,328
2022-01-13 2022-01-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
18,897 +0.1%
10.06
US$190,104 		18,897 +0.1% 10.06 US$190,104
2022-01-13 2022-01-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
18,897 +0.1%
10.06
US$190,104 		18,897 +0.1% 10.06 US$190,104
2022-01-13 2022-01-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
6,900 +0.0%
10.67
US$73,623 		6,900 +0.0% 10.67 US$73,623
2022-01-13 2022-01-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,600 +0.0%
9.81
US$15,696 		1,600 +0.0% 9.81 US$15,696
2022-01-13 2022-01-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
6,900 +0.0%
10.67
US$73,623 		6,900 +0.0% 10.67 US$73,623
2022-01-13 2022-01-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,600 +0.0%
9.81
US$15,696 		1,600 +0.0% 9.81 US$15,696
2021-12-22 2021-12-21 B Purchase
3.1
CLACKSON TIMOTHY P

President and CEO

Executive Director
2,600 +0.8%
9.76
US$25,381 		2,600 +0.8% 9.76 US$25,381
2021-12-22 2021-12-21 B Purchase
2.4
Dahms Bradford D.

Chief Financial Officer

Officer
1,970 +inf%
10.15
US$20,000 		1,970 +inf% 10.15 US$20,000
2021-10-14 2021-10-12 B Purchase
2.8
Rock Springs Capital Management LP
Large shareholder
250,000 +71.6%
16.00
US$4,000,000 		250,000 +71.6% 16.00 US$4,000,000
2021-10-14 2021-10-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
62,500 +14.3%
16.00
US$1,000,000 		62,500 +14.3% 16.00 US$1,000,000
2021-10-14 2021-10-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
562,500 +3.6%
16.00
US$9,000,000 		562,500 +3.6% 16.00 US$9,000,000
2021-10-14 2021-10-12 B Purchase
1.4
Shakespeare William

See Remarks

Officer
625 +0.2%
16.00
US$10,000 		625 +0.2% 16.00 US$10,000
2021-10-14 2021-10-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
62,500 +14.3%
16.00
US$1,000,000 		62,500 +14.3% 16.00 US$1,000,000
2021-10-14 2021-10-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
562,500 +3.6%
16.00
US$9,000,000 		562,500 +3.6% 16.00 US$9,000,000
2021-10-14 2021-10-12 B Purchase
3.3
Omega Fund VI, L.P.

Former 10% owner
187,500 +35.8%
16.00
US$3,000,000 		187,500 +35.8% 16.00 US$3,000,000
Explore more

More insider trading research around Theseus Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America